Navigation Links
The Hamner Institutes Announce Partnership With China Medical City
Date:5/20/2009

Agreement Creates New Bridge Between North Carolina And China

RESEARCH TRIANGLE PARK, N.C., May 20 /PRNewswire/ -- The Hamner Institutes for Health Sciences has signed an agreement with China Medical City to create the Hamner-China Medical City Institute for International Drug Development. Building on strengths of the two organizations in translational research, business development, and education, the Institute will help to produce new biomedical technologies that benefit the United States and People's Republic of China as well as the rest of the world.

During the first phase of this agreement, the Institute for International Drug Development will be established at The Hamner's campus in Research Triangle Park (RTP), North Carolina, and will focus on preclinical drug development and compliance with FDA regulatory standards. After the partners validate research capabilities and new technologies at The Hamner campus, they will transfer them to China Medical City, a new life science park located in the Yangtze River Delta north of Shanghai.

In 2008, The Hamner launched a Bioscience Accelerator on its 56-acre campus in the heart of RTP. There are two initial start-ups: BioMedomics, a diagnostics company started by Chinese-American scientists, and b3bio, a spinout from Duke University.

Newsummit Biopharma, one of China Medical City's premier partners, is establishing its North American business center in The Hamner's Bioscience Accelerator. Newsummit Biopharma is a contract research and technology development company whose service platform includes support for commercialization, intellectual property, funding, and staffing in science and technology parks throughout China.

The partnership with China Medical City and Newsummit Biopharma creates a vital bridge of opportunity between North Carolina and China. Acknowledged worldwide as a major hub of biotechnology, North Carolina is an ideal location for companies from China that seek to enter the U.S. market. After establishing an initial presence in RTP, which already has a strong Chinese community of scientists and business professionals, companies from China can expand around the state of North Carolina as their businesses prosper and grow.

As part of its new strategic agreement with China Medical City, The Hamner has worked with the North Carolina Department of Commerce and North Carolina Biotechnology Center, a world leader in bioscience development, to create a "North Carolina-China partner network" that supports Chinese business and educational initiatives. Other members of this innovative network include the North Carolina China Center, the North Carolina China Business Association, Council for Entrepreneurial Development, and North Carolina Research Parks Network as well as economic development organizations in counties such as Wake and Durham.

China Medical City and Newsummit Biopharma are actively using their network to assist North Carolina's R&D companies, contract organizations (research, manufacturing, and commercial), and academic institutions that want to establish strategic alliances, research sites, branch offices, etc. in China. The new Hamner Bioscience Center in China Medical City and the North Carolina Department of Commerce office in Shanghai are serving as gateways for North Carolina organizations, such as Cirrus, Specialty Operations Solutions, Inc., and SyneCor, that are developing new markets in China.

About the Hamner Institutes for Health Sciences

The Hamner Institutes for Health Sciences is a nonprofit research organization strategically located in Research Triangle Park, North Carolina. The Hamner has a strong heritage in scientific scholarship and translational research. For 35 years, scientists at The Hamner have conducted small-molecule chemical safety studies to protect the environment. The Hamner has recently expanded its mission to include drug safety, NIH-funded human disease research, and support for life science start-ups. As a neutral, independent research institute, The Hamner works collaboratively with academia, government regulatory agencies, and commercial companies to accelerate the development of new bioscience technologies. For more information, please see www.thehamner.org or call (919) 558-1200.

    The Hamner Institutes Media contact:
    Ryal Curtis
    MMI Associates, Inc.
    (919) 233-6600
    (919) 233-0300 (fax)
    ryal@mmimarketing.com


'/>"/>
SOURCE Hamner Institutes for Health Sciences
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. New Hamner-UNC Center for Drug Safety Sciences
2. UNC-Chapel Hill, Hamner Institutes Announce Partnership to Accelerate Basic, Translational Research
3. New Study Funded By the National Institutes of Health (NIH) Finds Masimo SpCO(R) May Provide a Noninvasive Measure of Acute Asthma Severity in Children
4. ImmunoVaccine Technologies Signs Agreement with National Institutes of Health to Explore Vaccines for HIV and Malaria
5. Cascades Technologies, Inc. and SAIC Team on $19 Million Contract with National Institutes of Health
6. Dr. Larry Corey Named New Member of the Institutes of Medicine
7. Albany College of Pharmacy Researcher Receives $368,445 Grant from the National Institutes of Health
8. Lixte Biotechnology Holdings Announces Extension of Its Cooperative Research and Development Agreement With The National Institute of Neurological Disorders and Stroke, National Institutes of Health, for Development of Anti-Brain Cancer Drugs
9. The Gladstone Institutes and iZumi Bio Announce Broad Partnership in Regenerative Medicine and Cardiovascular Disease
10. Lentigen Corporation Receives Four Research Grants From the National Institutes of Health
11. National Institutes of Health Awards $25.5M Contract to SRA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... , Feb. 4, 2016  Sangamo BioSciences, Inc. ... editing, announced today that Edward Lanphier , Sangamo,s ... on the progress of Sangamo,s ZFP Therapeutic ® ... strategy at 2:40 pm ET on Thursday, February 11, ... Global Healthcare Conference. The conference is being held in ...
(Date:2/4/2016)... SHENZHEN, China , Feb. 4, 2016 ... government, and various medical institutions attended a ceremony in ... provide integrative, personalized cell therapy in 2016. ... the "Shenzhen Clinical Translation Platform for Personalized Cell Therapy" ... Shenzhen Regional Cell Production Center, both subsidiaries of Beike ...
(Date:2/4/2016)... February 4, 2016 --> ... acceleration company is pleased to provide the following update on ... Over the last 3 months we have significantly increased ... agreements exceeding $1,000,000. As a result, we have positioned ourselves ... Inc. license agreement and expect that development to continue on ...
(Date:2/4/2016)... Sinovac Biotech Ltd. ("Sinovac" or the "Company") (NASDAQ: ... China , today announced that the ... February 4, 2016 a preliminary non-binding proposal letter, dated ... V-Ming ( Shanghai ) Investment Holdings Co., ... Shenzhen ) Fund Management Co., Ltd., Beijing ...
Breaking Biology Technology:
(Date:1/22/2016)... 22, 2016 ... the "Global Biometrics Market in Retail ... --> http://www.researchandmarkets.com/research/p74whf/global_biometrics ) has ... Biometrics Market in Retail Sector 2016-2020" ... Research and Markets ( http://www.researchandmarkets.com/research/p74whf/global_biometrics ) ...
(Date:1/20/2016)... Jan. 20, 2016 A market that just ... benefit from the explosion in genomics knowledge. Learn all ... Research. A range of dynamic trends are pushing market ... personalized medicine - pharmacogenomics - pathogen evolution - next ... markets - greater understanding of the role of genetic ...
(Date:1/20/2016)... 20, 2016  Synaptics Incorporated (NASDAQ: SYNA ... today announced sampling of S1423, its newest ClearPad ... small screen applications including smartwatches, fitness trackers, and ... and rectangular shapes, as well as thick and ... moisture on screen, while wearing gloves, and supports ...
Breaking Biology News(10 mins):